Initial Opioid Exposure in the ICU and 1-Year Opioid-Related Outcomes in Patients Who Are Mechanically Ventilated

Theodore J. Iwashyna MD, PhD , Elizabeth M. Viglianti MD, MPH , Jennifer Cano MPH , Sarah Seelye PhD , Nicholas A. Bosch MD , Lisa D. Burry PhD , Bijan Teja MD , David N. Juurlink MD, PhD , Henry T. Stelfox MD, PhD , Downing Lu MD, MPH , Andrea D. Hill PhD , Allan J. Walkey MD , Hannah Wunsch MD
{"title":"Initial Opioid Exposure in the ICU and 1-Year Opioid-Related Outcomes in Patients Who Are Mechanically Ventilated","authors":"Theodore J. Iwashyna MD, PhD ,&nbsp;Elizabeth M. Viglianti MD, MPH ,&nbsp;Jennifer Cano MPH ,&nbsp;Sarah Seelye PhD ,&nbsp;Nicholas A. Bosch MD ,&nbsp;Lisa D. Burry PhD ,&nbsp;Bijan Teja MD ,&nbsp;David N. Juurlink MD, PhD ,&nbsp;Henry T. Stelfox MD, PhD ,&nbsp;Downing Lu MD, MPH ,&nbsp;Andrea D. Hill PhD ,&nbsp;Allan J. Walkey MD ,&nbsp;Hannah Wunsch MD","doi":"10.1016/j.chstcc.2024.100124","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Little is known about whether the choice of opioid influences long-term outcomes for critically ill patients.</div></div><div><h3>Research Question</h3><div>To determine whether initiation of IV morphine or hydromorphone during mechanical ventilation (MV) is associated with reduced opioid use after discharge relative to fentanyl.</div></div><div><h3>Study Design and Methods</h3><div>This was a retrospective cohort study of 14,197 veterans who underwent MV in 116 Veterans Administration hospitals (2014-2020) and who received fentanyl, morphine, or hydromorphone as the initial and only IV opioid during their first 2 days in the ICU. The primary outcome was persistent opioid use in the year after hospital discharge.</div></div><div><h3>Results</h3><div>Overall, 11,903 patients (83.8%) received fentanyl, 1,156 patients (8.1%) received morphine, and 1,138 patients (8.0%) received hydromorphone as the initial and only IV opioid during the first 2 days in the ICU. The median patient age was 67 years (interquartile range, 61-72 years). Persistent opioid use in the year after discharge was more common with hydromorphone (16.5%) vs fentanyl (12.0%; adjusted OR [aOR], 1.25; 95% CI, 1.00-1.56), but not with morphine (15.7%) vs fentanyl (aOR, 1.12; 95% CI, 0.91-1.39). Stratified by prior persistent opioid use, the association between opioid initially received in the ICU and an increased risk of persistent use in the following year was present only among individuals without this history for both morphine and hydromorphine compared with fentanyl (morphine: aOR, 1.44 [95% CI, 1.07-1.94]; hydromorphone: aOR, 1.51 [95% CI, 1.12-2.04]).</div></div><div><h3>Interpretation</h3><div>Among patients in the ICU who received MV, persistent opioid use in the year after hospital discharge was more frequent among patients initially exposed to IV morphine or hydromorphone compared with fentanyl, but only among those without a prior history of persistent opioid use. The choice of initial opioid may have long-term consequences for patients. Further research is needed to confirm these exploratory findings.</div></div>","PeriodicalId":93934,"journal":{"name":"CHEST critical care","volume":"3 1","pages":"Article 100124"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CHEST critical care","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949788424000789","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Little is known about whether the choice of opioid influences long-term outcomes for critically ill patients.

Research Question

To determine whether initiation of IV morphine or hydromorphone during mechanical ventilation (MV) is associated with reduced opioid use after discharge relative to fentanyl.

Study Design and Methods

This was a retrospective cohort study of 14,197 veterans who underwent MV in 116 Veterans Administration hospitals (2014-2020) and who received fentanyl, morphine, or hydromorphone as the initial and only IV opioid during their first 2 days in the ICU. The primary outcome was persistent opioid use in the year after hospital discharge.

Results

Overall, 11,903 patients (83.8%) received fentanyl, 1,156 patients (8.1%) received morphine, and 1,138 patients (8.0%) received hydromorphone as the initial and only IV opioid during the first 2 days in the ICU. The median patient age was 67 years (interquartile range, 61-72 years). Persistent opioid use in the year after discharge was more common with hydromorphone (16.5%) vs fentanyl (12.0%; adjusted OR [aOR], 1.25; 95% CI, 1.00-1.56), but not with morphine (15.7%) vs fentanyl (aOR, 1.12; 95% CI, 0.91-1.39). Stratified by prior persistent opioid use, the association between opioid initially received in the ICU and an increased risk of persistent use in the following year was present only among individuals without this history for both morphine and hydromorphine compared with fentanyl (morphine: aOR, 1.44 [95% CI, 1.07-1.94]; hydromorphone: aOR, 1.51 [95% CI, 1.12-2.04]).

Interpretation

Among patients in the ICU who received MV, persistent opioid use in the year after hospital discharge was more frequent among patients initially exposed to IV morphine or hydromorphone compared with fentanyl, but only among those without a prior history of persistent opioid use. The choice of initial opioid may have long-term consequences for patients. Further research is needed to confirm these exploratory findings.
ICU初始阿片类药物暴露和机械通气患者1年阿片类药物相关结局
背景:对于阿片类药物的选择是否会影响危重患者的长期预后,我们知之甚少。研究问题:相对于芬太尼,确定在机械通气(MV)期间开始静脉注射吗啡或氢吗啡酮是否与出院后阿片类药物使用减少有关。研究设计和方法:本研究是一项回顾性队列研究,纳入了2014-2020年在116家退伍军人管理局医院接受MV治疗的14,197名退伍军人,这些退伍军人在ICU的头2天内接受芬太尼、吗啡或氢吗啡酮作为最初和唯一的静脉注射阿片类药物。主要结局是出院后一年内持续使用阿片类药物。结果在ICU前2天内,有11903例(83.8%)患者使用芬太尼,1156例(8.1%)使用吗啡,1138例(8.0%)使用氢吗啡酮作为最初和唯一的静脉阿片类药物。患者年龄中位数为67岁(四分位数范围为61-72岁)。出院后一年内持续使用阿片类药物更为常见,氢吗啡酮(16.5%)vs芬太尼(12.0%);调整后OR [aOR], 1.25;95% CI, 1.00-1.56),但吗啡(15.7%)与芬太尼(aOR, 1.12;95% ci, 0.91-1.39)。按既往持续使用阿片类药物分层,与芬太尼相比,在ICU首次接受阿片类药物与次年持续使用阿片类药物风险增加之间的关联仅存在于没有吗啡和氢吗啡使用史的个体中(吗啡:aOR, 1.44 [95% CI, 1.07-1.94];氢吗啡酮:aOR, 1.51 [95% CI, 1.12-2.04])。在接受MV的ICU患者中,与芬太尼相比,最初暴露于静脉注射吗啡或氢吗啡酮的患者在出院后一年持续使用阿片类药物的频率更高,但仅发生在没有持续使用阿片类药物病史的患者中。初始阿片类药物的选择可能会对患者产生长期影响。需要进一步的研究来证实这些探索性的发现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CHEST critical care
CHEST critical care Critical Care and Intensive Care Medicine, Pulmonary and Respiratory Medicine
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信